research
The Use of Recombinant Activated FVII (rFVIIa, Novoseven) in the Treatment of a Lifethreatening Retroperitoneal Hemorrhage in a Hemophilia A Patient with Inhibitors to FVIII
- Publication date
- 1 January 2000
- Publisher
- Serviço de Imuno-Hemoterapia do Hospital de S. José